Last reviewed · How we verify
NCT05850117
Efficacies of Tetracycline-levofloxacin, Standard Bismuth, Amoxicillin-levofloxacin Quadruple Therapy for H.p
NA trial testing esomeprazole, tripotassium dicitrate bismuthate, tetracycline and levofloxacin in Helicobacter Pylori Eradication in 240 participants. Status unknown.
31 December 2024
Quick facts
| Lead sponsor | Kaohsiung Medical University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 240 |
| Start date | 10 February 2020 |
| Primary completion | 31 December 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- esomeprazole, tripotassium dicitrate bismuthate, tetracycline and levofloxacin — full drug profile →
- esomeprazole , tripotassium dicitrate bismuthate, tetracycline 500mg and metronidazole — full drug profile →
- esomeprazole, tripotassium dicitrate bismuthate , amoxicillin and levofloxacin — full drug profile →
Conditions studied
- Helicobacter Pylori Eradication — all drugs for Helicobacter Pylori Eradication →
Sponsor
Kaohsiung Medical University
Who can join
20 and older, any sex, with Helicobacter Pylori Eradication. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
1. Compare the efficacy of "Tetracycline combined with levofloxacin quadruple therapy", "standard tincture quadruple therapy" and "amoxicillin combined with levofloxacin quadruple therapy" on the second line of Helicobacter pylori sterilization. 2. To investigate the drug resistance of Helicobacter pylori and the host genotypes of CYP2C19 and IL-1B-511 on the sterilizing effect of three second-line Helicobacter pylori.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05850117
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Helicobacter Pylori Eradication
Currently open trials in the same condition.
- NCT06349486 — Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy, Vonoprazan-amoxicillin Dual Therapy and Proton Pump Inhibit · NA · recruiting
Other Kaohsiung Medical University trials
Trials by the same sponsor.
- NCT07341620 — Effectiveness of an Online Interactive E-book in Enhancing Home Care Nurses' Knowledge, Perceived Barriers, and Self-eff · NA · recruiting
- NCT07297511 — Application of Multiple Vertical Jump Tests in Return-to-Play Assessment for Anterior Cruciate Ligament Reconstruction A · not yet recruiting
- NCT07337200 — The Effectiveness of Three Good Things on Gratitude and Psychological Well-being Among Nursing Students · NA · not yet recruiting
- NCT07375888 — The Application of an Innovative Reactive Agility Testing System for Assessment in Older Adults With Dynapenia · completed
- NCT07358130 — Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy and Bismuth Quadruple Therapy · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05850117 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kaohsiung Medical University
- Last refreshed: 9 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05850117.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing